Screening for Critical Congenital Heart Disease

Matthew E Oster; Lazaros Kochilas

doi:10.1016/j.clp.2015.11.005

Screening for Critical Congenital Heart Disease

Clin Perinatol. 2016 Mar;43(1):73-80. doi: 10.1016/j.clp.2015.11.005.

Authors

Matthew E Oster¹, Lazaros Kochilas²

Affiliations

¹ Children's Healthcare of Atlanta, Atlanta, GA, USA; Emory University School of Medicine, Atlanta, GA, USA. Electronic address: osterm@kidsheart.com.
² Children's Healthcare of Atlanta, Atlanta, GA, USA; Emory University School of Medicine, Atlanta, GA, USA.

PMID: 26876122
DOI: 10.1016/j.clp.2015.11.005

Abstract

Screening for critical congenital heart disease (CCHD) was added to the United States Recommended Uniform Screening Panel in 2011. Since that time, CCHD screening with pulse oximetry has become nearly universal for newborns born in the United States. There are various algorithms in use. Although the goal of the screening program is to identify children who may have CCHD, most newborns who have a low oxygen saturation will not have CCHD. Further study is needed to determine optimal guidelines for CCHD screening in special settings such as the neonatal intensive care unit, areas in high altitude, and home births.

Keywords: Critical congenital heart disease; Newborn screening; Pulse oximetry.

Publication types

Review

MeSH terms

Critical Illness
Heart Defects, Congenital / complications
Heart Defects, Congenital / diagnosis*
Humans
Hypoxia / diagnosis*
Hypoxia / etiology
Infant, Newborn
Neonatal Screening / methods
Oximetry / methods
Sensitivity and Specificity
United States